Breaking News

Financial Report: INC Research

February 25, 2016

Revenues up 23% in the quarter

INC Research
4Q Revenues:
$402.9 million (+23%)

4Q Earnings: $30.7 million (loss of $53.2 million 4Q14)

FY Revenues: $1.4 billion (+19%)

FY Earnings: $117 million (loss of $23.5 million FY14)

Comments: Book-to-bill was 1.2x for the quarter and 1.3x for the year. Net new business awards were $297.4 million in the quarter and $1.18 billion for the year.
Revenue growth during both the fourth quarter and fiscal year 2015 was driven primarily by continued strong awards over the last two years, a lower cancellation rate of previously awarded business and a positive revenue mix. In 2015, revenue grew across all therapeutic areas and was particularly strong in complex therapeutic areas.
blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision